Anti-Microbial Savior BioteQ Co., Ltd. (TPEX: 6864)
Health Care · Biotechnology · TW
NT$41.85
-0.48% today · -51.3% 1Y
Anti-Microbial Savior BioteQ Co., Ltd. (TPEX: 6864) operates in the Biotechnology industry within the Health Care sector. The company is valued at $49.47M and employs 15 people.
Over the last twelve months the share price has lost 51.3%, trading between 40.00 and 96.20.
Tweenvest scores Anti-Microbial Savior BioteQ Co., Ltd. across four factors: quality 31/100, growth 84/100. Its strongest factor is growth.
6864 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.47M
- Revenue (TTM)
- $22.48K
- P/E
- —
- EPS
- -2.88
- Dividend yield
- —
- Beta (5Y)
- -0.08
- 52-week high
- NT$96.20
- 52-week low
- NT$40.00
- Avg volume (3M)
- —
- Shares outstanding
- 37.82M
- Employees
- 15
- Next earnings
- —
About Anti-Microbial Savior BioteQ Co., Ltd.
Established in 2018, Anti-Microbial Savior BioteQ Co., Ltd. is a Kaohsiung, Taiwan-based enterprise primarily engaged in the research and development of medicinal drugs.
- ISIN
- TW0006864002
- Founded
- 2018
- Listed since
- Dec 29, 2021
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.